Abdelaty E M, Schumacher H R
Department of Physical Medicine, Alexandria University, Egypt.
Int J Clin Pract. 1999 Oct-Nov;53(7):535-9.
Better understanding of the immunopathogenesis of rheumatoid arthritis over the past few decades has promoted the innovation of new therapeutic approaches targeting the disease more specifically. In addition, refinements in the non-steroidal anti-inflammatory drugs (NSAID) may offer advantages for patients with RA. This brief review reports and analyses some of the important aspects of these new therapies available for treatment of RA and in which situations you might consider each. Before using any of these agents, physicians should become thoroughly familiar with the package inserts.
在过去几十年中，对类风湿性关节炎免疫发病机制的更深入了解推动了更具针对性地治疗该疾病的新疗法的创新。此外，非甾体抗炎药（NSAID）的改进可能会给类风湿性关节炎患者带来益处。本简要综述报告并分析了可用于治疗类风湿性关节炎的这些新疗法的一些重要方面，以及在哪些情况下你可能会考虑使用每种疗法。在使用任何这些药物之前，医生应彻底熟悉药品说明书。
